Skip to content

Author

M. Khormi

We have 5 of 41 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Engineering next-generation CAR-NK cells for hematological malignancies: genome editing, synthetic biology, and precision immunotherapy

Chimeric antigen receptor (CAR)-based immunotherapy has transformed cancer treatment by enabling engineered immune cells to selectively recognize and eliminate malignant targets, with CAR-T cells establishing the first major clinical success in this field. However, severe associated toxicities, logistical complexitie...

A. Bahr, Youssef Basem, Amani Alhejely et al. · 0 citations
Open access Aug 2026

A comparative study of the antidiabetic and cardiopulmonary protective effects of Moringa oleifera and liraglutide in a rat model of alloxan-induced diabetes

Diabetes mellitus is one of the biggest health problems in the world, increasingly linked to complications in multiple organs, including significant cardiopulmonary dysfunction. Agonists of the glucagon-like peptide-1 (GLP-1) receptor provide efficient glycemic control; however, their accessibility remains limited in...

Amal Naif Alshammari, Iman K. Abdel Gadir, Amal A. Abdulbaqi et al. · 0 citations
Open access Aug 2026

Uncovering a hidden diversity of aquatic bacteriophages: ecological diversity, untapped therapeutic potential, and water quality control

The graphical abstract displays generalized information regarding the source and application of phages. According to the figure, natural water bodies and wastewater treatment plants are considered to be the major sources of lytic phages. These phages can be utilized for various activities, including lowering the bact...

S. Al-maaqar, Wael A. Alsubhi, Zakia F. Albalawy et al. · 0 citations
Open access Aug 2026

Curcumin Targets the Spleen–Brain Axis in Diabetes: A Comparative Study with Liraglutide via JAK2/STAT3 Signaling

From the current findings, curcumin has multiple therapeutic targets as an alternative to liraglutide and may possess the capacity to modulate neuroimmune dysfunction in diabetes by protecting the spleen–brain axis through JAK2/STAT3 modulation.

M. Khormi, Amal Naif Alshammari, R. A. Hegazy et al. · 0 citations
Open access 2026

Phytochemical profiling and in vitro antioxidant, cytotoxic, and digestive enzyme inhibitory activities of ethanolic fenugreek (Trigonella foenum-graecum L.) seed extract

Findings demonstrate the fenugreek seed extract’s in vitro antioxidant activity, preferential cytotoxicity toward the tested cancer cell lines, and inhibitory effects on pancreatic lipase and carbohydrate-digesting enzymes.

N. H. Aljarba, M. Khormi, Hamida Hamdi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.